Latest News

PR Newswire

Senhwa Biosciences Highlights Breakthroughs in Dual First-in-Class Drug Programs at Annual Shareholders' Meeting Today

Jun

25

2025

LABIOTECH

Seven biotech companies keeping Taiwan dynamic in 2025

Mar

07

2025

PennState Health

Penn State College of Medicine, Beat Childhood Cancer Research Consortium and Four Diamonds launch clinical trial that aims to combat solid tumors

Sep

30

2024

YAHOO FINANCE

Senhwa Biosciences Announces IND Submission to US FDA for Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors sponsored by NCI

Sep

18

2024

YAHOO FINANCE

AACR 2024 Annual Meeting-Visit Senhwa Biosciences Exhibit Booth

Apr

03

2024

PR Newswire

Senhwa Biosciences Announces First Patient Successfully Dosed in Taiwan Phase II Study of Silmitasertib in Hospitalized Adults with COVID-19

Nov

09

2023

PR Newswire

Senhwa Biosciences Announces IND Submission to US FDA for Phase II Study of Silmitasertib in Patients with Community-Acquired Pneumonia (CAP) Associated with Viral Infection

Oct

19

2023

Bloomberg

Senhwa Biosciences Announces Successful Awardee of Anticancer Pipeline, Pidnarulex, in NIH-Sponsored NExT Program

Dec

01

2022